Christopher G. Kanakry

National Institutes of Health — United States

Medicine · Health Sciences

32h-index5.0kcitations162works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(113), Immune Cell Function and Interaction(44), T-cell and B-cell Immunology(29), Acute Myeloid Leukemia Research(27), Acute Lymphoblastic Leukemia research(27)

Publications162 total

Association of pharmacokinetic biomarkers with early immune recovery following HLA-haploidentical hematopoietic cell transplantation
Frontiers in Immunology·2025Open Access
Demodicosis and Ivermectin-Associated Mazzotti-Like Reactions After Hematopoietic Cell Transplant
JAMA Dermatology·2025Open Access
VerSe Data Augmentation Enables per Vertebral Body Instance Segmentation in HSCT Patient Scans
2025
Unrelated Donor Age and Recipient Outcomes After Posttransplant Cyclophosphamide vs Conventional Prophylaxis
JAMA Oncology·2025· 2 citedOpen Access
Connecting pharmacokinetic exposure to immune reconstitution: A pilot study in HLA-haploidentical hematopoietic cell transplant recipients
Blood·2025Open Access
T cell exhaustion in focus: single-cell mapping of CD8+ T cell dynamics in mucosal chronic graft-versus-host disease 3680
The Journal of Immunology·2025Open Access
Exhausted-like effector CD8 T cells mediate immune-stromal interactions at mucosal Chronic Graft-versus-Host Disease onset
2025Open Access
BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant
Blood Advances·2025Open Access
Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 Years
Open Forum Infectious Diseases·2025Open Access
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
Blood Advances·2025· 1 citedOpen Access
Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations
Transplantation and Cellular Therapy·2025· 5 citedOpen Access
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis
Transplantation and Cellular Therapy·2025· 1 cited
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation
American Journal of Hematology·2025· 2 citedOpen Access
Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins
Theranostics·2025· 3 citedOpen Access
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
Blood Advances·2025· 18 citedOpen Access
REMOVED: Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Mature NK/T Cell Neoplasms – Potent Graft Vs Tumor Effect Affords Remission Even with Refractory Disease
Transplantation and Cellular Therapy·2025Open Access
REMOVED: Post-Transplantation Cyclophosphamide Protects the Thymus from Alloreactive T-Cell Damage after T-Cell-Replete MHC-Haploidentical Hematopoietic Cell Transplantation but Does Not Rescue Normal Medullary Thymic Epithelial Cell Differentiation or Intrathymic Clonal Deletion.
Transplantation and Cellular Therapy·2025Open Access
REMOVED: Dosing-Dependent Effects of Post-Transplantation Cyclophosphamide (PTCy) on Human Early Immune Responses: Insights from Single-Cell Analysis
Transplantation and Cellular Therapy·2025Open Access
REMOVED: Understanding the Nature of the Alloreactive T-Cell Dysfunction Induced By Post-Transplantation Cyclophosphamide
Transplantation and Cellular Therapy·2025Open Access
REMOVED: Intravenous Hyperhydration Is Not Mandatory to Prevent Post-Transplantation Cyclophosphamide (PTCy)-Induced Hemorrhagic Cystitis in Patients Receiving Mesna
Transplantation and Cellular Therapy·2025Open Access
page 1 of 9Next →

Frequent Co-authors

Leo Luznik(17), Ephraim J. Fuchs(14), Jennifer A. Kanakry(12), Richard J. Jones(10), Javier Bolaños‐Meade(9), Taiga Nishihori(9), Hillard M. Lazarus(8), Michael R. Grunwald(8), Daniel J. Weisdorf(8), Robert A. Brodsky(7), Carol Ann Huff(7), William Matsui(7), Ivan Borrello(7), Richard F. Ambinder(7), Amer Beitinjaneh(7), Miguel Ángel Díaz(7), Siddhartha Ganguly(7), Nelli Bejanyan(7), Partow Kebriaei(7), Shannon R. McCurdy(6)